118 related articles for article (PubMed ID: 25296107)
1. Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q.
Vanlander AV; Okun JG; de Jaeger A; Smet J; De Latter E; De Paepe B; Dacremont G; Wuyts B; Vanheel B; De Paepe P; Jorens PG; Van Regenmortel N; Van Coster R
Anesthesiology; 2015 Feb; 122(2):343-52. PubMed ID: 25296107
[TBL] [Abstract][Full Text] [Related]
2. Effects of resveratrol on the rat brain respiratory chain.
Zini R; Morin C; Bertelli A; Bertelli AA; Tillement JP
Drugs Exp Clin Res; 1999; 25(2-3):87-97. PubMed ID: 10370869
[TBL] [Abstract][Full Text] [Related]
3. Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome.
Vanlander AV; Jorens PG; Smet J; De Paepe B; Verbrugghe W; Van den Eynden GG; Meire F; Pauwels P; Van der Aa N; Seneca S; Lissens W; Okun JG; Van Coster R
Acta Anaesthesiol Scand; 2012 Apr; 56(4):520-5. PubMed ID: 22260353
[TBL] [Abstract][Full Text] [Related]
4. Propofol induces a metabolic switch to glycolysis and cell death in a mitochondrial electron transport chain-dependent manner.
Sumi C; Okamoto A; Tanaka H; Nishi K; Kusunoki M; Shoji T; Uba T; Matsuo Y; Adachi T; Hayashi JI; Takenaga K; Hirota K
PLoS One; 2018; 13(2):e0192796. PubMed ID: 29447230
[TBL] [Abstract][Full Text] [Related]
5. [Effect of prolonged infusion of propofol on the liver mitochondria respiratory function in rabbits].
Tong XX; Kang Y; Liu FZ; Zhang WS; Liu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):1021-3. PubMed ID: 21265107
[TBL] [Abstract][Full Text] [Related]
6. Effects of Propofol on Cellular Bioenergetics in Human Skeletal Muscle Cells.
Krajčová A; Løvsletten NG; Waldauf P; Frič V; Elkalaf M; Urban T; Anděl M; Trnka J; Thoresen GH; Duška F
Crit Care Med; 2018 Mar; 46(3):e206-e212. PubMed ID: 29240609
[TBL] [Abstract][Full Text] [Related]
7. Propofol Is Mitochondrion-Toxic and May Unmask a Mitochondrial Disorder.
Finsterer J; Frank M
J Child Neurol; 2016 Nov; 31(13):1489-1494. PubMed ID: 27488955
[TBL] [Abstract][Full Text] [Related]
8. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.
Lalani SR; Vladutiu GD; Plunkett K; Lotze TE; Adesina AM; Scaglia F
Arch Neurol; 2005 Feb; 62(2):317-20. PubMed ID: 15710863
[TBL] [Abstract][Full Text] [Related]
9. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
10. Kinetic characteristics of propofol-induced inhibition of electron-transfer chain and fatty acid oxidation in human and rodent skeletal and cardiac muscles.
Urban T; Waldauf P; Krajčová A; Jiroutková K; Halačová M; Džupa V; Janoušek L; Pokorná E; Duška F
PLoS One; 2019; 14(10):e0217254. PubMed ID: 31584947
[TBL] [Abstract][Full Text] [Related]
11. In vitro evidence that D-serine disturbs the citric acid cycle through inhibition of citrate synthase activity in rat cerebral cortex.
Zanatta A; Schuck PF; Viegas CM; Knebel LA; Busanello EN; Moura AP; Wajner M
Brain Res; 2009 Nov; 1298():186-93. PubMed ID: 19733154
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.
Larsen S; Stride N; Hey-Mogensen M; Hansen CN; Bang LE; Bundgaard H; Nielsen LB; Helge JW; Dela F
J Am Coll Cardiol; 2013 Jan; 61(1):44-53. PubMed ID: 23287371
[TBL] [Abstract][Full Text] [Related]
13. Lipid emulsion, but not propofol, induces skeletal muscle damage and lipid peroxidation.
Chaki T; Hirata N; Yoshikawa Y; Tachibana S; Tokinaga Y; Yamakage M
J Anesth; 2019 Dec; 33(6):628-635. PubMed ID: 31473808
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of propofol tolerance conferred by remifentanil co-administration does not reduce propofol toxicity in rabbits under prolonged mechanical ventilation.
Ypsilantis P; Politou M; Mikroulis D; Lambropoulou M; Bougioukas I; Theodoridis G; Tsigalou C; Manolas C; Papadopoulos N; Bougioukas G; Simopoulos C
J Surg Res; 2011 Jun; 168(2):253-61. PubMed ID: 20036388
[TBL] [Abstract][Full Text] [Related]
15. The propofol infusion 'syndrome' in intensive care unit: from pathophysiology to prophylaxis and treatment.
Papaioannou V; Dragoumanis C; Theodorou V; Pneumatikos I
Acta Anaesthesiol Belg; 2008; 59(2):79-86. PubMed ID: 18652104
[TBL] [Abstract][Full Text] [Related]
16. The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats.
Kitamura T; Ogawa M; Kawamura G; Sato K; Yamada Y
Anesth Analg; 2009 Nov; 109(5):1479-85. PubMed ID: 19843785
[TBL] [Abstract][Full Text] [Related]
17. Changes in skeletal muscle, heart and liver mitochondrial electron transport activities in rats and dogs of various ages.
Sugiyama S; Takasawa M; Hayakawa M; Ozawa T
Biochem Mol Biol Int; 1993 Aug; 30(5):937-44. PubMed ID: 8220242
[TBL] [Abstract][Full Text] [Related]
18. Preservation of mitochondrial respiratory function by coenzyme Q10 in aged rat skeletal muscle.
Sugiyama S; Yamada K; Ozawa T
Biochem Mol Biol Int; 1995 Dec; 37(6):1111-20. PubMed ID: 8747541
[TBL] [Abstract][Full Text] [Related]
19. [Effects of propofol infusion on respiration, systemic circulation and regional organ blood flow].
Fukushima M; Matsumoto N
Masui; 1999 Oct; 48(10):1105-12. PubMed ID: 10554502
[TBL] [Abstract][Full Text] [Related]
20. Lethal outcomes: propofol infusion syndrome and propofol abuse.
O'Malley P
Clin Nurse Spec; 2010; 24(1):8-10. PubMed ID: 20010177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
